EUVIMEDEUVIMED entdecken
Open Access

Clinicopathological and molecular characterization of non–small cell lung cancer with pericardial effusions

Weijie Ma iD, Nathalie J Rodrigues Simoes, Peter P Seery, Tianhong Li iD, Laura J Tafe iD, Darcy A Kerr iD, Xiaoying Liu iD

Cancer Cytopathology · 2025

DOI: 10.1002/cncy.70015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cytopathology, 2025. Verfasst von Weijie Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, …. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pericardial Effusion. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cytological evaluation is essential for assessing pericardial effusions (PEs) in non–small cell lung cancer (NSCLC). This study retrospectively examined the clinicopathological, molecular, and prognostic characteristics of patients with NSCLC with PE.

Methods

Clinical data from 80 patients with NSCLC with PE treated at an academic center over the course of 15 years were reviewed. PE specimens were categorized according to the International System for Reporting Serous Fluid Cytopathology (ISRSFC). The analysis included patient demographics, molecular alterations, cytopathology, histology, and survival outcomes.

Results

Of the 80 patients, 36 (45%) were female and 90% had stage IV disease. A smoking history was noted in 58 patients (72.5%), and 22 patients (27.5%) presented with tamponade. Lung adenocarcinoma predominated (87.5%). The ISRSFC categorized 25% of the specimens as negative for malignancy (NFM), 7.5% as atypia of undetermined significance (AUS), 3.75% as suspicious for malignancy (SFM), and 63.75% as malignant (MAL). Immunohistochemistry in 57 specimens identified thyroid transcription factor 1 (65%) as the most frequently positive marker. Molecular analysis revealed p53 mutations (59.1%) as the most prevalent, followed by KRAS (34.1%) and EGFR (15.9%). Kaplan–Meier analysis showed significantly better survival for NFM patients than non‐NFM patients (MAL, SFM, and AUS; p = .0036). Bloody PEs and tamponade were associated with worse outcomes. The immunotherapy group achieved the most prolonged survival among stage IV patients (9.07 months; p = .017). Cox regression confirmed cytology‐negative status as an independent prognostic factor.

Conclusions

Cytological evaluation and ISRSFC classification are crucial for NSCLC‐associated PEs. A multidisciplinary approach integrating cytology, immunohistochemistry, and molecular profiling is essential for optimal management and prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsPericardial EffusionHumansFemaleMaleMiddle AgedAgedRetrospective StudiesPrognosisAdultAged, 80 and overBiomarkers, TumorMutationNeoplasm Staging

Stichwörter der Autor:innen

International System for Reporting Serous Fluid Cytopathology (ISRSFC)biomarkermolecular characterizationnon–small cell lung cancerpericardial effusionsprognosis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
  • Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, California, USA.

ORCID-Profile: Weijie Ma, Tianhong Li, Laura J Tafe, Darcy A Kerr, Xiaoying Liu

Förderung

  • BLRD VA
  • NCI NIH HHS

Zitieren

APA

Ma, W., Rodrigues Simoes, N. J., Seery, P. P., Li, T., Tafe, L. J., Kerr, D. A., & Liu, X. (2025). Clinicopathological and molecular characterization of non–small cell lung cancer with pericardial effusions. Cancer Cytopathology. https://doi.org/10.1002/cncy.70015

Vancouver

Ma W, Rodrigues Simoes NJ, Seery PP, Li T, Tafe LJ, Kerr DA, et al. Clinicopathological and molecular characterization of non–small cell lung cancer with pericardial effusions. Cancer Cytopathology. 2025. doi:10.1002/cncy.70015

BibTeX
@article{Ma2025,
  author = {Ma, Weijie and Rodrigues Simoes, Nathalie J and Seery, Peter P and Li, Tianhong and Tafe, Laura J and Kerr, Darcy A and Liu, Xiaoying},
  title = {Clinicopathological and molecular characterization of non–small cell lung cancer with pericardial effusions},
  journal = {Cancer Cytopathology},
  year = {2025},
  doi = {10.1002/cncy.70015}
}
Kostenlos starten →